|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/7125 | |
| A61K 31/713 | |||
| A61P 35/00 | |||
| A61P 35/04 |
| (11) | Patento numeris | 3302502 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16727089.1 |
| Europos patento paraiškos padavimo data | 2016-05-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-04-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-08-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/033817 |
| Data | 2016-05-23 |
| (87) | Numeris | WO 2016/196062 |
| Data | 2016-12-08 |
| (30) | Numeris | Data | Šalis |
| 201562168449 P | 2015-05-29 | US | |
| 201562168470 P | 2015-05-29 | US | |
| 201562169309 P | 2015-06-01 | US | |
| 201562169321 P | 2015-06-01 | US | |
| 201662276767 P | 2016-01-08 | US |
| (72) |
GUIDUCCI, Cristiana, US
COFFMAN, Robert L., US
|
| (73) |
Dynavax Technologies Corporation,
2929 Seventh Street, Suite 100, Berkeley, CA 94710,
US
|
| (54) | INTRAPULMONARY ADMINISTRATION OF POLYNUCLEOTIDE TOLL-LIKE RECEPTOR 9 AGONISTS FOR TREATING CANCER OF THE LUNG |
| INTRAPULMONARY ADMINISTRATION OF POLYNUCLEOTIDE TOLL-LIKE RECEPTOR 9 AGONISTS FOR TREATING CANCER OF THE LUNG |